The Current Strategies for Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer: The Place of Immunotherapy in Future

Journal Title: The Bulletin of Urooncology - Year 2020, Vol 19, Issue 3

Abstract

Muscle invasion is present in approximately thirty percent of bladder cancers. Radical cystectomy and bilateral pelvic lymph node dissection following neoadjuvant chemotherapy is the recommended treatment for muscle invasive bladder cancer. Local and distant relapses are seen in a significant proportion of patients with surgery alone. Micrometastases at the time of diagnosis that cannot be detected by imaging may be responsible for these relapses. The aim of neoadjuvant and adjuvant therapies is to eliminate these micrometastases. Several randomized trials have shown that platinum-based combination neoadjuvant chemotherapy can improve survival outcomes, compared with locoregional treatment alone. Although the proportion of patients receiving treatment has increased compared to previous years, it is still low. Immunotherapies in neoadjuvant treatment are promising in the appropriate patient group. In this article, we aimed to review current neoadjuvant treatment strategies in muscle invasive bladder cancer in the literature.

Authors and Affiliations

Özlem Ercelep

Keywords

Related Articles

Comparison of Prostate Cancer Detection Rates of Cognitive Fusion-targeted Biopsy and Standard Transrectal Ultrasound-guided Biopsy

Objective: The aim of this study is to investigate whether there is a difference between standard prostate needle biopsies and cognitive fusion prostate biopsies (classical 12-core plus 2 cognitive lesions) for any prost...

“Atypical Cell’’ Parameter in Automated Urine Analysis for the Diagnosis of Bladder Cancer: A Retrospective Pilot Study

Objective: To evaluate the application of an automated urine analyzer (AUA) for the diagnosis of bladder cancer (BC). Materials and Methods: A retrospective data analysis of 2365 urine specimens from the department of u...

Evaluation of General Features of Patients with Testicular Cancer

Objective: Testicular cancers (Tca) are most common in men aged 20-34. Despite the increase in its incidence, the mortality rate from Tca decreases. In our study, it was aimed to evaluate the general characteristics, the...

The Role of Adrenal Cortex-Sparing Surgery for Bilateral Masses in Three Cases

Pheochromocytoma are the functional adrenal lesions originating from the chromaffin cells. For the cases of pheochromocytoma observed in multiple endocrine neoplasia Type 2 and Von Hippel syndrome, the bilateral adrenal...

Laparoscopic Extraperitoneal Radical Prostatectomy

Radical prostatectomy (RP) involves removing the entire prostate with its capsule intact and the seminal vesicles (SV). In this video article, we summarized the extraperitoneal laparoscopic RP with pelvic lymph node diss...

Download PDF file
  • EP ID EP688784
  • DOI 10.4274/uob.galenos.2020.1447
  • Views 122
  • Downloads 0

How To Cite

Özlem Ercelep (2020). The Current Strategies for Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer: The Place of Immunotherapy in Future. The Bulletin of Urooncology, 19(3), -. https://europub.co.uk./articles/-A-688784